Here are three quick points:
1. Vericel is a developer of patient-specific expanded cellular therapies.
2. Matricel is a developer, manufacturer and marketer of medical devices and pharmaceutical excipients, including biocompatible matrices in regenerative medicine.
3. The agreement is related to the United States registration of the ACI-Maix collagen membrane used in the manufacture of MACI, which is Vericel’s investigational third-generation autologous-cultured chondrocyte implant.
More articles on devices:
500th Navio knee surgery performed at Cornerstone Regional Hospital: 5 key notes
Alphatec Spine, LDR, Globus Medical & more — 21 key notes
DJO Surgical unveils its EMPOWR 3D Knee system: 5 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
